Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study-Reference-Cited by-同舟云学术

Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study

Published:2016-05 Issue:5 Volume:48 Page:552-558
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Ruszniewski Philippe,Valle Juan W.,Lombard-Bohas Catherine,Cuthbertson Daniel J.,Perros Petros,Holubec Luboš^ORCID,Delle Fave Gianfranco,Smith Denis,Niccoli Patricia,Maisonobe Pascal,Atlan Philippe,Caplin Martyn E.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. An update on gastroenteropancreatic neuroendocrine tumors;Cives;Oncology (Williston Park),2014

2. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification;Anlauf;Hormone and Metabolic Research,2011

3. Neuroendocrine tumors of the gastro-entero-pancreatic system;Massironi;World Journal of Gastroenterology,2008

4. Gastrointestinal neuroendocrine tumors;Oberg;Annals of Oncology,2010

5. Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population;Beaumont;Pancreas,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors;Expert Opinion on Drug Safety;2024-06-10

2. PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK;Supportive Care in Cancer;2024-02-29

3. From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms;Therapeutic Advances in Medical Oncology;2024-01

4. Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

5. OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel;European Journal of Endocrinology;2023-08